Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Trillium Therapeutics Inc. T.TRIL

Trillium Therapeutics Inc is a clinical-stage immuno-oncology company that is engaged in developing therapies for the treatment of cancer. It has two clinical programs, TTI-621 and TTI-622, that target CD47. The company operates in the United States and Canada.


TSX:TRIL - Post by User

Bullboard Posts
Comment by tradingsteveon Jul 26, 2010 12:18pm
292 Views
Post# 17296869

RE: RE: RE: RE: RE: RE: RE: Patents

RE: RE: RE: RE: RE: RE: RE: Patentseasymoney321......

Don't go cry now my friend!....Thank you for admitting all you do is " venture" a "guess". Would you care to come clean about anything else?

And no my friend, I do not, nor have I ever, held Nortel shares. I was just adding some realism to your overly optimistic views. You guys just get upset when I provide some valid comentary, responding to your mostly unfounded assertions....or as you put it...."guess"es
Bullboard Posts